This site is intended for healthcare professionals only
LoginRegister
COVID-19 Update: Health Ministry informs about steps taken for containment and managementCOVID-19 Update: Health Ministry informs about steps taken for containment and management
SEC Approves Serums Salk Polio Vaccine for Commercial Use, Recommends Phase I Trial for 21-valent Pneumococcal VaccineCoronavirus vaccine: SII to give 2 crore Covishield doses worth Rs 410 crore to Central govt free of...
Bharat Biotech, Biological E together hold about 250 million COVID vaccine dosesBharat Biotech, Biological E together hold about 250 million COVID vaccine doses
Aurobindo Pharma arm Rajasthan facility gets 9 USFDA observationsAurobindo Pharma JV Tergene gets CDSCO panel recommendation for 15-valent Pneumococcal...
COVID intranasal vaccine: Bharat Biotech iNCOVACC priced at Rs 800 for private hospitals, Rs 325 for GovtCOVID intranasal vaccine: Bharat Biotech iNCOVACC priced at Rs 800 for private hospitals, Rs 325 for...
BioNTech, Fosun Pharma get full regulatory approval for COMIRNATY in individuals 12 years and older in Hong KongBioNTech, Fosun Pharma get full regulatory approval for COMIRNATY in individuals 12 years and older...
Research shows COVID-19 booster increases durability of antibody responseResearch shows COVID-19 booster increases durability of antibody response
Moderna fires back at Pfizer counterclaims in COVID vaccine patent lawsuitModerna fires back at Pfizer counterclaims in COVID vaccine patent lawsuit
Centre nod to Bharat Biotech nasal COVID vaccine iNCOVACC, to be availabile in private hospitalsCentre nod to Bharat Biotech nasal COVID vaccine iNCOVACC, to be availabile in private hospitals
SEC Approves Serums Salk Polio Vaccine for Commercial Use, Recommends Phase I Trial for 21-valent Pneumococcal VaccineCOVID vaccine: SII seeks DCGI nod for market authorisation of Covovax as booster dose
Bivalent mRNA booster vaccine reduces risk of severe COVID-19 by more than half: CDCBivalent mRNA booster vaccine reduces risk of severe COVID-19 by more than half: CDC
European Commission approves Qdenga as second dengue virus vaccineEuropean Commission approves Qdenga as second dengue virus vaccine
X